II. Indications

  1. Atrial Fibrillation Cardioversion
    1. Time to Cardioversion: 3-6h
    2. Conversion Rate: 38-86%
    3. Chronic Efficacy: 47-60%

III. Mechanism

  1. Class Ia Antiarrhythmic

IV. Dosing

  1. Dose: 324-648 mg PO q8h

Images: Related links to external sites (from Bing)

Related Studies